Cases & Deals

ADOCIA initiates Level I ADR program in United States

Client(s) ADOCIA

Jones Day advised ADOCIA, a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins, in connection with the implementation of its Level I American Depositary Receipt Program for the U.S. market with the Bank of New York Mellon on the OTC Markets.